仁和药业：2025年第三季度归属于上市公司股东的净利润同比增长13.00%

Core Insights - Renhe Pharmaceutical reported a revenue of 858,360,283.90 yuan for Q3 2025, representing a year-on-year growth of 9.16% [1] - The net profit attributable to shareholders of the listed company was 88,708,927.17 yuan, showing a year-on-year increase of 13.00% [1]